obesity

Arena's Lorcaserin: Therapeutic Value Zero?
Seeking Alpha
Tue, 09/14/10 - 10:15 am
Arena Pharmaceuticals
lorcaserin
obesity
What Arena Investors Should Worry About
Forbes
Mon, 09/13/10 - 08:22 pm
Arena Pharmaceuticals
obesity
FDA
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Arena Pharmaceuticals
obesity
Vivus
Qnexa
Contrave
Orexigen
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
Seeking Alpha
Mon, 09/6/10 - 10:04 am
Arena Pharmaceuticals
obesity
lorcaserin
Qnexa
Meridia
Vivus
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Fri, 09/3/10 - 11:57 am
Arena Pharmaceuticals
Contrave
Orexigen
Vivus
obesity
Qnexa
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thu, 09/2/10 - 08:18 am
Orexigen
Takeda
obesity
Contrave
partnerships
Vivus' Qnexa Panel Bodes Well for Arena's Obesity Drug
Seeking Alpha
Mon, 08/30/10 - 10:44 am
Qnexa
Vivus
advisory panels
Arena Pharmaceuticals
obesity
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Fri, 08/27/10 - 11:10 am
Arena Pharmaceuticals
obesity
FDA
Vivus
Orexigen
Contrave
Qnexa
Novo Nordisk To Test Victoza In Anti-Obesity - CEO
WSJ Online
Tue, 08/24/10 - 08:01 am
obesity
Novo Nordisk
Victoza
Sanofi Study Looks Like Image Rehab for Diet Drug Linked to Suicides
BNET Pharma
Mon, 08/16/10 - 10:07 am
obesity
Zimulti
Sanofi
FDA advisors to weigh Meridia's safety
Fierce Pharma
Mon, 08/9/10 - 11:07 am
FDA
Meridia
obesity
Abbott Laboratories
Arena's Obesity Drug Likely to Pass FDA Panel With Flying Colors
Seeking Alpha
Mon, 08/9/10 - 09:46 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Contrave
Qnexa
FDA
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Vivus
downgrades
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Fri, 07/30/10 - 11:05 am
Orexigen
obesity
Contrave
Vivus
Arena Pharmaceuticals
Vivus's Obesity Drug Raises Familiar Questions
Seeking Alpha
Mon, 07/26/10 - 11:16 am
Vivus
obesity
Arena Pharmaceuticals
Contrave
Orexigen
Qnexa
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wed, 07/21/10 - 03:55 pm
obesity
Vivus
Qnexa
FDA
Arena Pharmaceuticals
Contrave
Orexigen
FDA approves Lannett’s generic for Sandoz weight-loss drug
Bizjournals.com
Tue, 07/20/10 - 03:31 pm
Sandoz
obesity
Lannett
generics
FDA
Arena Weight Loss Drug Looks Promising
Seeking Alpha
Tue, 07/20/10 - 07:20 am
Arena Pharmaceuticals
obesity
Lessons Learned About the Outlook for New Obesity Drug Approval
Motley Fool
Sun, 07/18/10 - 07:43 am
obesity
Arena Pharmaceuticals
Vivus
Qnexa
Contrave
Orexigen
Vivus: What Happens Next?
TheStreet.com
Fri, 07/16/10 - 08:21 am
Vivus
Qnexa
obesity
Contrave
Arena Pharmaceuticals
Orexigen
FDA

Pages